This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Korea Research Institute of Chemical Technology. Active years: 1999-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2010
Title: Innovations by Bong-Jin Kim
Introduction
Bong-Jin Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of antibacterial compounds, particularly through his innovative research and development of carbapenem derivatives. His work has implications for treating resistant bacterial infections, which is a growing concern in modern medicine.
Latest Patents
Bong-Jin Kim holds 2 patents that showcase his expertise in the development of novel antibacterial agents. His latest patents include:
1. **2-arylmethylazetidine carbapenem derivatives and preparation thereof** - This patent describes a 2-arylmethylazetidine carbapenem derivative that exhibits a wide spectrum of antibacterial activities against both Gram-positive and Gram-negative bacteria. It is particularly effective against resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA) and quinolone-resistant strains (QRS).
2. **β-methylcarbapenem derivatives, process for the preparation thereof** - This patent details a β-methylcarbapenem compound and its preparation process, along with an antibacterial composition that includes the compound. The formula specifies that R¹ can be a C₁-₆ alkyl, C₂-₆ alkenyl, cycloalkyl, aryl, or heterocyclic aryl group.
Career Highlights
Bong-Jin Kim is affiliated with the Korea Research Institute of Chemical Technology, where he conducts his research. His work is pivotal in the ongoing battle against antibiotic resistance, and he continues to explore new avenues for effective antibacterial treatments.
Collaborations
Throughout his career, Bong-Jin Kim has collaborated with esteemed colleagues, including Jae-Hak Kim and Cheol-Hae Lee. These collaborations have further enriched his research and contributed to the advancement of antibacterial technologies.
Conclusion
Bong-Jin Kim's innovative work in the field of antibacterial compounds highlights his importance as an inventor. His patents reflect a commitment to addressing critical health challenges posed by resistant bacteria. His contributions are vital for the future of antibacterial therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile